CRON FY2025 SEC EDGAR DEF 14A #40 of 168 in industry

Cronos Group Inc. CEO pay ratio

The CEO earned $4.1M in FY2025 against median worker pay of $36,354 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
A1
Filing date
2026-04-24
Industry
Chemicals & Pharmaceuticals
Industry rank
#40/168

Data updated August 2026

Subscribe to Cronos Group Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
112:1
Moderate (Scale: 0–1000:1)
CEO pay
$4.1M
Median worker
$36,354

Answer first

Cronos Group Inc.'s FY2025 CEO total of $4.1M ranks #997 of 1,423 complete filings; its 112:1 pay ratio ranks #586. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $36,354. Industry placement uses the FY2025 SIC-28 peer cohort (# 40 of 168, 77th percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#997
$4.1M of 1,423 FY2025
Ratio rank
#586
112:1 of 1,423
Industry pct
77th
top quartile of industry peers by pay ratio

How Cronos Group Inc. ranks nationally

Cronos Group Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$4,071,626 30th percentile higher than 30% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). This entry sits in this band. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Cronos Group Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($4.1M) against pay ratio (112:1) for Cronos Group Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3092907.18475861.013858815.019241768.924624722.938.4:158.2:178:197.8:1117.6:1CEO total payPay ratio (CEO : median worker)Cronos Group Inc., CEO total pay: 4071626 · Pay ratio (CEO : median worker): 112:1Cronos Group Inc.Biogen Inc., CEO total pay: 23646004 · Pay ratio (CEO : median worker): 113:1Biogen Inc.Ani Pharmaceuticals Inc, CEO total pay: 10254756 · Pay ratio (CEO : median worker): 114:1Ani Pharmaceuticals IncPerimeter Solutions, Inc., CEO total pay: 8062080 · Pay ratio (CEO : median worker): 114:1Perimeter Solutions, Inc.Biomarin Pharmaceutical Inc, CEO total pay: 21927563 · Pay ratio (CEO : median worker): 109:1Biomarin Pharmaceutical Inc
Cronos Group Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Cronos Group Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Cronos Group Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
112:1
FY2025
vs prior FY
+55:1
from FY2024 57:1
CEO $ YoY
-1.9%
$4.1M latest
Filings shown
4
FY2021–2025
Cronos Group Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $1.8M - $47,895 38:1 -
2023 $3.7M +104% $51,527 72:1 +34:1
2024 $4.2M +12% $72,820 57:1 -15:1
2025 $4.1M -1.9% $36,354 112:1 +55:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1656472, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
112:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$4.1M
Companies in Industry
168
vs. Industry Median
Above
#40 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Cronos Group Inc.: MID · MID$ pay ratio

Cronos Group Inc.'s FY2025 ratio 112:1 ranks #40 of 168 Chemicals & Pharmaceuticals filers (77th percentile). the CEO earned 112× the median employee ($36,354) in FY2025.

Median employee $36,354 (LOW-MED); MID · MID$ stamps put about 112 median-wage years per CEO year.

CEO Total Pay

$4.1M

FY2025 Summary Compensation, below median

Pay Ratio

112:1

Near industry median

Cronos Group Inc. in the higher Chemicals & Pharmaceuticals third

Cronos Group Inc.'s FY2025 ratio 112:1 ranks #40 of 168 Chemicals & Pharmaceuticals filers (77th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Cronos Group Inc.'s $4.1M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #997 and ratio rank #586 split - treat 112:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$4.1M
Median Employee Pay
$36,354
Pay Ratio
112:1
Filing Date
2026-04-24

Company Info

Ticker
CRON
CIK
1656472
Industry
Chemicals & Pharmaceuticals
SIC Code
2833
State
A1
View SEC filings →
SEC EDGAR DEF 14A for CIK 1656472, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Cronos Group Inc.'s FY2025 ratio 112:1 ranks #40 of 168 Chemicals & Pharmaceuticals filers (77th percentile).

Read with Cronos Group Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · MID$ · LOW-MED.

USA TODAY Co., Inc. · MID$

ABS(ceo_total_comp) peer at $4.1M (Δ $14K heavier vs Cronos Group Inc.); MODEST · PAR-MED vs this page's MID · MID$ · LOW-MED.
Shoe Station Group Inc · MID$

ABS(ceo_total_comp) peer at $4.1M (Δ $21K lighter vs Cronos Group Inc.); STEEP · LOW-MED vs this page's MID · MID$ · LOW-MED.
ChargePoint Holdings, Inc. · MID$

ABS(ceo_total_comp) peer at $4.1M (Δ $41K heavier vs Cronos Group Inc.); MODEST · HIGH-MED vs this page's MID · MID$ · LOW-MED.
First Busey Corp /NV/ · MID$

ABS(ceo_total_comp) peer at $4.0M (Δ $42K lighter vs Cronos Group Inc.); FLOOR · HIGH-MED vs this page's MID · MID$ · LOW-MED.
Biogen Inc. (SIC 28 pole)

Biogen Inc. stamps MID · PEAK nearest in-SIC by ABS(pay_ratio) to Cronos Group Inc.'s MID filing.
National dual ranks · #997/#586

Cronos Group Inc.'s FY2025 package sits #997 by CEO dollars and #586 by ratio under MID$ · MID.
Pay-equity trends · MID

Cronos Group Inc.'s MID · LOW-MED stamps sit mid-band - pay-equity trends place the ratio against workforce pay.
Data sourced from SEC EDGAR DEF 14A for Cronos Group Inc. (CIK 1656472), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.